Literature DB >> 30841433

Curcumin suppresses wilms' tumor metastasis by inhibiting RECK methylation.

Wei Jia1, Fuming Deng2, Wen Fu2, Jinhua Hu2, Guifang Chen2, Xiaofeng Gao2, Xiangliang Tan2, Guoyuan Li2, Guochang Liu2, Shibo Zhu3.   

Abstract

Wilms' tumor (WT) is the most common kidney tumor of children. The transformation suppressor gene RECK, which codes membrane-anchored glycoprotein, frequently downregulates multiple matrix metalloproteinases in tumors. And curcumin, which is a polyphenlic compound separated from turmeric, has antitumor effects on various cancers. However, the correlation of WT, RECK and curcumin is still unrevealed. In this study, we evaluated that the methylation degree of RECK was much higher in WT than in adjacent non-tumor tissues. And RECK methylation was closely associated with tumor metastasis in WT patients. After curcumin treatment, the level of RECK methylation was decreased significantly. And the expression of MMP2 and MMP9 was reduced consequently. Moreover, the proliferation, invasion and migration ability of WT cells were suppressed after curcumin treatment. Meanwhile, the apoptosis rate of WT cells was increased simultaneously. In nude mice model, curcumin restrained ability of tumorigenicity and promoted apoptosis of WT cells. Together, our results suggest that the RECK methylation can serve as a prognostic biomarker of WT. Moreover, curcumin could inhibit RECK methylation, thereby abates the expression of MMPs, and suppresses the tumor progression and metastasis of WT.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Curcumin; Metastasis; Methylation; RECK; Wilms' tumor

Mesh:

Substances:

Year:  2019        PMID: 30841433     DOI: 10.1016/j.biopha.2018.12.111

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour.

Authors:  Jialin Meng; Yonghao Chen; Xiaofan Lu; Qintao Ge; Feixiang Yang; Suwen Bai; Chaozhao Liang; Juan Du
Journal:  Comput Struct Biotechnol J       Date:  2022-06-27       Impact factor: 6.155

2.  Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs.

Authors:  Jian Yuan; Wen Li; Jinxiao Zhu; Shuli Deng; Xuejin Tao
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 3.  Diet-derived small molecules (nutraceuticals) inhibit cellular proliferation by interfering with key oncogenic pathways: an overview of experimental evidence in cancer chemoprevention.

Authors:  Mohammad Fahad Ullah; Aamir Ahmad; Showket H Bhat; Faisel M Abuduhier; Syed Khalid Mustafa; Shazia Usmani
Journal:  Biol Futur       Date:  2022-01-17

4.  Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.

Authors:  Yuxiu Shen; Zaigang Han; Shuang Liu; Yang Jiao; Ying Li; Hongyan Yuan
Journal:  Cancer Manag Res       Date:  2020-02-27       Impact factor: 3.989

5.  Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells.

Authors:  Pan Liu; Qian Ying; Huan Liu; Si-Qi Yu; Lu-Ping Bu; Liang Shao; Xin-Yi Li
Journal:  Oncol Rep       Date:  2020-08-03       Impact factor: 3.906

6.  RNA-Sequencing, Connectivity Mapping, and Molecular Docking to Investigate Ligand-Protein Binding for Potential Drug Candidates for the Treatment of Wilms Tumor.

Authors:  Jia-Yuan Luo; Shi-Bai Yan; Gang Chen; Peng Chen; Song-Wu Liang; Qiong-Qian Xu; Jin-Han Gu; Zhi-Guang Huang; Li-Ting Qin; Hui-Ping Lu; Wei-Jia Mo; Yi-Ge Luo; Jia-Bo Chen
Journal:  Med Sci Monit       Date:  2020-03-26

Review 7.  Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review.

Authors:  Bo Hong; Rui Dong
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.